# APREPITANT
> **ANDA218851** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2026-03-05
## Drug
- **FDA Application Number:** ANDA218851
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** APREPITANT
- **Generic name:** Aprepitant
- **Active ingredients:** APREPITANT
- **Dosage form:** EMULSION
- **Route:** INTRAVENOUS
- **Marketing status:** Discontinued
- **Sponsor:** MYLAN
- **First approval:** 2026-03-05
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218851)
---
*MORVS · CC0 1.0*